Header Logo

Connection

MATTHEW HAROLD KATZ to Drug Synergism

Back to Details
This is a "connection" page, showing publications MATTHEW HAROLD KATZ has written about Drug Synergism.
MATTHEW HAROLD KATZ
Connection Strength
0.073
Drug Synergism
  1. Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther. 2010 Jul; 9(7):2068-78.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.